<!DOCTYPE html>
<html lang="en-us">
  <head><script src="/livereload.js?mindelay=10&amp;v=2&amp;port=1313&amp;path=livereload" data-no-instant defer></script>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
    
    <title>Impact of MEKi on learning | SPiN-LAB Studying Plasticity in Neurodevelopment</title>
    <meta name="viewport" content="width=device-width,minimum-scale=1">
    <meta name="description" content="
What is this study about
In this study, we’ll be using different tests to see how MEK inhibitors (MEKi -a medicine taken for some of the physical symptoms of NF1) affect learning, attention and mood in children with NF1.">
    <meta name="generator" content="Hugo 0.134.2">
    
    
    
    
      <meta name="robots" content="noindex, nofollow">
    

    
<link rel="stylesheet" href="/ananke/css/main.min.css" >



    
    
    
      

    

    
    
    <meta property="og:url" content="http://localhost:1313/current-studies/currstud-1/">
  <meta property="og:site_name" content="SPiN-LAB Studying Plasticity in Neurodevelopment">
  <meta property="og:title" content="Impact of MEKi on learning">
  <meta property="og:description" content="
What is this study about In this study, we’ll be using different tests to see how MEK inhibitors (MEKi -a medicine taken for some of the physical symptoms of NF1) affect learning, attention and mood in children with NF1.">
  <meta property="og:locale" content="en_us">
  <meta property="og:type" content="article">
    <meta property="article:section" content="current-studies">

  <meta itemprop="name" content="Impact of MEKi on learning">
  <meta itemprop="description" content="
What is this study about In this study, we’ll be using different tests to see how MEK inhibitors (MEKi -a medicine taken for some of the physical symptoms of NF1) affect learning, attention and mood in children with NF1.">
  <meta itemprop="wordCount" content="329">
  <meta name="twitter:card" content="summary">
  <meta name="twitter:title" content="Impact of MEKi on learning">
  <meta name="twitter:description" content="
What is this study about In this study, we’ll be using different tests to see how MEK inhibitors (MEKi -a medicine taken for some of the physical symptoms of NF1) affect learning, attention and mood in children with NF1.">

	
  </head>

  <body class="ma0 avenir bg-near-white">

    
   
  

  
  <header class="cover bg-top" style="background-image: url('http://localhost:1313/images/Background_Images/spin-lab-background.png');">
    <div class="bg-black-60">
      <nav class="pv3 ph3 ph4-ns" role="navigation">
  <div class="flex-l justify-between items-center center">
    <a href="/" class="f3 fw2 hover-white no-underline white-90 dib">
      
        <img src="/images/Logos/logo.png" class="w100 mw5-ns" alt="SPiN-LAB Studying Plasticity in Neurodevelopment" />
      
    </a>
    <div class="flex-l items-center">
      

      
        <ul class="pl0 mr3">
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white no-underline white-90" href="/about/" title="About page">
              About
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white no-underline white-90" href="/news/" title="News page">
              News
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white no-underline white-90" href="/people/" title="People page">
              People
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white no-underline white-90" href="/publications/" title="Publications page">
              Publications
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white no-underline white-90" href="/lab-manual/" title="Lab Manual page">
              Lab Manual
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white no-underline white-90" href="/current-studies/" title="Current Studies page">
              Current Studies
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white no-underline white-90" href="/contact/" title="Contact page">
              Contact
            </a>
          </li>
          
        </ul>
      
      
<div class="ananke-socials">
  
    
    <a href="https://twitter.com/GoHugoIO" target="_blank" rel="noopener" class="twitter ananke-social-link link-transition stackoverflow link dib z-999 pt3 pt0-l mr1" title="Twitter link" aria-label="follow on Twitter——Opens in a new window">
      
        <span class="icon"><svg style="enable-background:new 0 0 67 67;" version="1.1" viewBox="0 0 67 67"  xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><path d="M37.167,22.283c-2.619,0.953-4.274,3.411-4.086,6.101  l0.063,1.038l-1.048-0.127c-3.813-0.487-7.145-2.139-9.974-4.915l-1.383-1.377l-0.356,1.017c-0.754,2.267-0.272,4.661,1.299,6.271  c0.838,0.89,0.649,1.017-0.796,0.487c-0.503-0.169-0.943-0.296-0.985-0.233c-0.146,0.149,0.356,2.076,0.754,2.839  c0.545,1.06,1.655,2.097,2.871,2.712l1.027,0.487l-1.215,0.021c-1.173,0-1.215,0.021-1.089,0.467  c0.419,1.377,2.074,2.839,3.918,3.475l1.299,0.444l-1.131,0.678c-1.676,0.976-3.646,1.526-5.616,1.568  C19.775,43.256,19,43.341,19,43.405c0,0.211,2.557,1.397,4.044,1.864c4.463,1.377,9.765,0.783,13.746-1.568  c2.829-1.673,5.657-5,6.978-8.221c0.713-1.716,1.425-4.851,1.425-6.354c0-0.975,0.063-1.102,1.236-2.267  c0.692-0.678,1.341-1.419,1.467-1.631c0.21-0.403,0.188-0.403-0.88-0.043c-1.781,0.636-2.033,0.551-1.152-0.402  c0.649-0.678,1.425-1.907,1.425-2.267c0-0.063-0.314,0.042-0.671,0.233c-0.377,0.212-1.215,0.53-1.844,0.72l-1.131,0.361l-1.027-0.7  c-0.566-0.381-1.361-0.805-1.781-0.932C39.766,21.902,38.131,21.944,37.167,22.283z M33,64C16.432,64,3,50.569,3,34S16.432,4,33,4  s30,13.431,30,30S49.568,64,33,64z" style="fill-rule:evenodd;clip-rule:evenodd;"/></svg>
</span>
      
<span class="new-window"><svg  height="8px"  style="enable-background:new 0 0 1000 1000;" version="1.1" viewBox="0 0 1000 1000"  xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" >
<path d="M598 128h298v298h-86v-152l-418 418-60-60 418-418h-152v-86zM810 810v-298h86v298c0 46-40 86-86 86h-596c-48 0-86-40-86-86v-596c0-46 38-86 86-86h298v86h-298v596h596z" style="fill-rule:evenodd;clip-rule:evenodd;"/>
</svg>
</span></a>
  
</div>

    </div>
  </div>
</nav>

      <div class="tc-l pv6 ph3 ph4-ns">
        
      </div>
    </div>
  </header>



    <main class="pb7" role="main">
      
  
  <article class="flex-l flex-wrap justify-between mw8 center ph3">
    <header class="mt4 w-100">
      <aside class="instapaper_ignoref b helvetica tracked">
          
        CURRENT STUDIES
      </aside>
      










  <div id="sharing" class="mt3 ananke-socials">
    
      
      <a href="https://twitter.com/share?url=http://localhost:1313/current-studies/currstud-1/&amp;text=Impact%20of%20MEKi%20on%20learning" class="ananke-social-link twitter no-underline" aria-label="share on Twitter">
        
        <span class="icon"> <svg style="enable-background:new 0 0 67 67;" version="1.1" viewBox="0 0 67 67"  xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><path d="M37.167,22.283c-2.619,0.953-4.274,3.411-4.086,6.101  l0.063,1.038l-1.048-0.127c-3.813-0.487-7.145-2.139-9.974-4.915l-1.383-1.377l-0.356,1.017c-0.754,2.267-0.272,4.661,1.299,6.271  c0.838,0.89,0.649,1.017-0.796,0.487c-0.503-0.169-0.943-0.296-0.985-0.233c-0.146,0.149,0.356,2.076,0.754,2.839  c0.545,1.06,1.655,2.097,2.871,2.712l1.027,0.487l-1.215,0.021c-1.173,0-1.215,0.021-1.089,0.467  c0.419,1.377,2.074,2.839,3.918,3.475l1.299,0.444l-1.131,0.678c-1.676,0.976-3.646,1.526-5.616,1.568  C19.775,43.256,19,43.341,19,43.405c0,0.211,2.557,1.397,4.044,1.864c4.463,1.377,9.765,0.783,13.746-1.568  c2.829-1.673,5.657-5,6.978-8.221c0.713-1.716,1.425-4.851,1.425-6.354c0-0.975,0.063-1.102,1.236-2.267  c0.692-0.678,1.341-1.419,1.467-1.631c0.21-0.403,0.188-0.403-0.88-0.043c-1.781,0.636-2.033,0.551-1.152-0.402  c0.649-0.678,1.425-1.907,1.425-2.267c0-0.063-0.314,0.042-0.671,0.233c-0.377,0.212-1.215,0.53-1.844,0.72l-1.131,0.361l-1.027-0.7  c-0.566-0.381-1.361-0.805-1.781-0.932C39.766,21.902,38.131,21.944,37.167,22.283z M33,64C16.432,64,3,50.569,3,34S16.432,4,33,4  s30,13.431,30,30S49.568,64,33,64z" style="fill-rule:evenodd;clip-rule:evenodd;"/></svg>
</span>
        
      </a>
    
  </div>


      <h1 class="f1 athelas mt3 mb1">Impact of MEKi on learning</h1>
      
      
      

      
      
    </header>
    <div class="nested-copy-line-height lh-copy serif f4 nested-links mid-gray pr4-l w-two-thirds-l"><p><img src="/images/News_Images/MEK_Image2.jpg" alt="img"></p>
<h3 id="what-is-this-study-about">What is this study about</h3>
<p>In this study, we’ll be using different tests to see how MEK inhibitors (MEKi -a medicine taken for some of the physical symptoms of NF1) affect learning, attention and mood in children with NF1.</p>
<h3 id="why-is-this-study-being-done">Why is this study being done?</h3>
<p>Children with NF1 are more likely to have some trouble with learning, memory and/or paying attention than their classmates.  Right now, we don’t fully understand why this is and there aren’t any treatments that specifically help with these problems in NF1. We hope this study will help us understand more about how the brain works in NF1, and one day lead to new treatments made just for these difficulties .</p>
<h3 id="what-are-we-doing">What are we doing?</h3>
<p>We are going to work with young people and their families who are just starting to take MEKi to explore the impact of the medication on different aspects of the brain and body.</p>
<h3 id="how-will-we-do-this">How will we do this?</h3>
<p>We will use a variety of methods including:</p>
<ul>
<li>EEG</li>
<li>Eye-tracking</li>
<li>Questionnaires</li>
<li>Brain games</li>
</ul>
<p>Some young people will also have their blood looked at and can take part in a conversation with researchers about any changes they’ve noticed after taking the medication for a few months.</p>
<h3 id="who-can-take-part">Who can take part?</h3>
<p>We are looking for young people and their families under the age of 18 who are about to start taking MEK inhibitors.
Young people who have been taking MEKi for under a year are welcome to take part in the conversation about the medication if they would like (but wouldn’t be able to do the other parts).</p>
<h3 id="study-timeline">Study Timeline</h3>
<p>This study is currently recruiting, and it is expected to run until spring 2027.</p>
<h3 id="where-can-i-find-out-more">Where can I find out more?</h3>
<p>We’d love to hear from you so if you have any questions or would like to talk to us about taking part please email us at: <a href="mailto:nfresearch@manchester.ac.uk">nfresearch@manchester.ac.uk</a></p>
<p>Alternatively, the study information leaflets (click below/link) have more information if you’d like to find out more.</p><ul class="pa0">
  
</ul>
<div class="mt6 instapaper_ignoref">
      
      
      </div>
    </div>

    <aside class="w-30-l mt6-l">




</aside>

  </article>

    </main>
    <footer class="dark-gray bottom-0 w-100 pa3" role="contentinfo">
  <div class="flex justify-between">
  <a class="f4 fw4 hover-white no-underline white-70 dn dib-ns pv2 ph3" href="http://localhost:1313/" >
    &copy;  SPiN-LAB Studying Plasticity in Neurodevelopment 2025 
  </a>
    <div>
<div class="ananke-socials">
  
    
    <a href="https://twitter.com/GoHugoIO" target="_blank" rel="noopener" class="twitter ananke-social-link link-transition stackoverflow link dib z-999 pt3 pt0-l mr1" title="Twitter link" aria-label="follow on Twitter——Opens in a new window">
      
        <span class="icon"><svg style="enable-background:new 0 0 67 67;" version="1.1" viewBox="0 0 67 67"  xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><path d="M37.167,22.283c-2.619,0.953-4.274,3.411-4.086,6.101  l0.063,1.038l-1.048-0.127c-3.813-0.487-7.145-2.139-9.974-4.915l-1.383-1.377l-0.356,1.017c-0.754,2.267-0.272,4.661,1.299,6.271  c0.838,0.89,0.649,1.017-0.796,0.487c-0.503-0.169-0.943-0.296-0.985-0.233c-0.146,0.149,0.356,2.076,0.754,2.839  c0.545,1.06,1.655,2.097,2.871,2.712l1.027,0.487l-1.215,0.021c-1.173,0-1.215,0.021-1.089,0.467  c0.419,1.377,2.074,2.839,3.918,3.475l1.299,0.444l-1.131,0.678c-1.676,0.976-3.646,1.526-5.616,1.568  C19.775,43.256,19,43.341,19,43.405c0,0.211,2.557,1.397,4.044,1.864c4.463,1.377,9.765,0.783,13.746-1.568  c2.829-1.673,5.657-5,6.978-8.221c0.713-1.716,1.425-4.851,1.425-6.354c0-0.975,0.063-1.102,1.236-2.267  c0.692-0.678,1.341-1.419,1.467-1.631c0.21-0.403,0.188-0.403-0.88-0.043c-1.781,0.636-2.033,0.551-1.152-0.402  c0.649-0.678,1.425-1.907,1.425-2.267c0-0.063-0.314,0.042-0.671,0.233c-0.377,0.212-1.215,0.53-1.844,0.72l-1.131,0.361l-1.027-0.7  c-0.566-0.381-1.361-0.805-1.781-0.932C39.766,21.902,38.131,21.944,37.167,22.283z M33,64C16.432,64,3,50.569,3,34S16.432,4,33,4  s30,13.431,30,30S49.568,64,33,64z" style="fill-rule:evenodd;clip-rule:evenodd;"/></svg>
</span>
      
<span class="new-window"><svg  height="8px"  style="enable-background:new 0 0 1000 1000;" version="1.1" viewBox="0 0 1000 1000"  xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" >
<path d="M598 128h298v298h-86v-152l-418 418-60-60 418-418h-152v-86zM810 810v-298h86v298c0 46-40 86-86 86h-596c-48 0-86-40-86-86v-596c0-46 38-86 86-86h298v86h-298v596h596z" style="fill-rule:evenodd;clip-rule:evenodd;"/>
</svg>
</span></a>
  
</div>
</div>
  </div>
</footer>

  </body>
</html>
